BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8953114)

  • 1. Anaerobic bacteremia.
    Goldstein EJ
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S97-101. PubMed ID: 8953114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of and outcomes for Bacteroides fragilis bacteremia.
    Cheng CW; Lin HS; Ye JJ; Yang CC; Chiang PC; Wu TS; Lee MH
    J Microbiol Immunol Infect; 2009 Jun; 42(3):243-50. PubMed ID: 19812858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attributable mortality of bacteremia associated with the Bacteroides fragilis group.
    Redondo MC; Arbo MD; Grindlinger J; Snydman DR
    Clin Infect Dis; 1995 Jun; 20(6):1492-6. PubMed ID: 7548498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaerobic bacteremia: the yield of positive anaerobic blood cultures: patient characteristics and potential risk factors.
    Saito T; Senda K; Takakura S; Fujihara N; Kudo T; Linuma Y; Fujita N; Komori T; Baba N; Horii T; Matsuoka K; Tanimoto M; Ichiyama S
    Clin Chem Lab Med; 2003 Mar; 41(3):293-7. PubMed ID: 12705336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of reduced susceptibility in the Bacteroides fragilis group isolated from blood cultures--the first national survey in Denmark.
    Justesen US; Hansen F; Østergaard C; Schønheyder HC; Hansen DS; Lemming LE; Schumacher H; Heltberg O; Knudsen JD; Dzajic E; Arpi M; Hammerum AM
    Int J Antimicrob Agents; 2013 Aug; 42(2):188-90. PubMed ID: 23773329
    [No Abstract]   [Full Text] [Related]  

  • 6. Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.
    Spánik S; Trupl J; Kunová A; Pichna P; Helpianska L; Ilavská I; Kukucková E; Lacka J; Grausová S; Stopková K; Drgona L; Krcméry V
    Neoplasma; 1996; 43(4):235-8. PubMed ID: 8931747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reemergence of anaerobic bacteremia.
    Lassmann B; Gustafson DR; Wood CM; Rosenblatt JE
    Clin Infect Dis; 2007 Apr; 44(7):895-900. PubMed ID: 17342637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteroides fragilis: a case study of bacteremia and septic arthritis.
    Martin T; Aziz H
    Clin Lab Sci; 2009; 22(3):131-5. PubMed ID: 19827405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period.
    Fenner L; Widmer AF; Straub C; Frei R
    J Clin Microbiol; 2008 Jul; 46(7):2432-4. PubMed ID: 18463219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobic bacteremia: decreasing rate over a 15-year period.
    Dorsher CW; Rosenblatt JE; Wilson WR; Ilstrup DM
    Rev Infect Dis; 1991; 13(4):633-6. PubMed ID: 1925283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics associated with mortality of patients with anaerobic bacteremia.
    Umemura T; Hamada Y; Yamagishi Y; Suematsu H; Mikamo H
    Anaerobe; 2016 Jun; 39():45-50. PubMed ID: 26903282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteroides fragilis bacteremia and infected aortic aneurysm presenting as fever of unknown origin: diagnostic delay without routine anaerobic blood cultures.
    O'Donnell JA; Asbel LE
    Clin Infect Dis; 1999 Nov; 29(5):1309-11. PubMed ID: 10524981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical review: bacteremia caused by anaerobic bacteria in children.
    Brook I
    Crit Care; 2002 Jun; 6(3):205-11. PubMed ID: 12133179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Goldstein EJ
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S106-11. PubMed ID: 12173118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance.
    Lombardi DP; Engleberg NC
    Am J Med; 1992 Jan; 92(1):53-60. PubMed ID: 1731510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are incidence and epidemiology of anaerobic bacteremia really changing?
    Vena A; Muñoz P; Alcalá L; Fernandez-Cruz A; Sanchez C; Valerio M; Bouza E
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1621-9. PubMed ID: 26017663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates.
    Claros MC; Claros ZC; Hecht DW; Citron DM; Goldstein EJ; Silva J; Tang-Feldman Y; Rodloff AC
    Anaerobe; 2006 Feb; 12(1):17-22. PubMed ID: 16701608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteremia caused by Bacteroides. An analysis of 50 episodes].
    Berenguer J; Cuadros JA; Betriu C; Muñoz P; Moreno JJ
    Enferm Infecc Microbiol Clin; 1989; 7(6):307-11. PubMed ID: 2490445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of enterotoxigenic Bacteroides fragilis with bacteremia.
    Kato N; Kato H; Watanabe K; Ueno K
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S83-6. PubMed ID: 8953112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
    Hung MN; Chen SY; Wang JL; Chang SC; Hsueh PR; Liao CH; Chen YC
    J Microbiol Immunol Infect; 2005 Dec; 38(6):436-43. PubMed ID: 16341345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.